For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220202:nRSB3897Aa&default-theme=true
RNS Number : 3897A Alpha Growth PLC 02 February 2022
The information communicated within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulation (EU) No.
596/2014 (as in force in the United Kingdom pursuant to the European Union
(Withdrawal) Act 2018). Upon the publication of this announcement, this inside
information is now considered to be in the public domain
Alpha Growth Plc
("Alpha", or the "Company")
BlackOak Alpha Growth Fund managed by the Group continues its Growth and
Performance
Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services
specialist in the growing longevity asset class, is pleased to announce the
results for the year-ended 31 December 2021 for its BlackOak Alpha Growth Fund
(the "Fund") investing in Senior Life Settlements ("SLS").
The Fund in 2021, has seen significant positive inflows of investment,
doubling its assets under management to ~$45 million and achieving a
compounded annual growth rate (CAGR) of 112% since January 2020.
BOAGF AUM January 2020: ~$10m
BOAGF AUM January 2021: ~$22m
BOAGF AUM January 2022: ~$45m
On a net basis, the Fund produced a total return of 18.9%, annualized 7.7%
since inception in September 2019, and monthly returns of 0.6%. The Fund has
achieved positive returns in 27 out of the 28 months it has been operational.
At 2021 year end the Fund owned 96 SLS with a total face value of
$79,626,819.83 and average life expectancy of 73 months. The minimum is
$100,000 and maximum face value is $5,000,000 with an average face value of
$829,446.04.
The Company continues to actively market the Fund to registered investment
advisors in the US and supplements this direct outreach by showcasing the Fund
at virtual events.
Danny Swick, COO and co-GP of the Fund stated "We continue to go from strength
to strength and have received a very positive reception by investors that look
for consistent and uncorrelated returns and yield over multi-year periods. We
continue to build our portfolio of SLS into a well-diversified pool of
policies and remain focused on investing in quality SLS to meet our investment
objectives on behalf of our investors."
Gobind Sahney, Executive Chairman, added "The Alpha Growth team continues to
perform exceptionally well and have once again more than doubled the size of
the Fund over a 12 month period. During this period, the Fund held 25% of its
assets in cash, however as the fund continues to grow and mature, we would
expect this figure to reduce to circa 15% - this will have a net positive
impact on future reported returns."
Gobind continued "Alpha continues to build on its business plan of accreting
assets under management and growing long term revenue through its steady focus
on the fund and insurance business segments. Providence Life Assurance Company
(Bermuda) Ltd continues to perform well and is increasing its balance sheet
assets. We have successfully made a number of strategic advances in both
business segments recently and I look forward to updating our shareholders
when appropriate."
For more information, please visit www.algwplc.com or contact the following:
Alpha Growth Plc +44 (0) 20 3959 8600
Gobind Sahney, Executive Chairman info@algwplc.com (mailto:info@algwplc.com)
BlackOak Alpha Growth Funds +1 949-326-9799
www.boagf.com (http://www.boagf.com)
Arden Partners plc +44 (0) 20 7614 5900
Ruari McGirr / Alexandra Campbell-Harris (Corporate Finance)
UK Investor Relations - Mark Treharne ir@algwplc.com (mailto:ir@algwplc.com)
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist
consultancy, advisory, and supplementary services to institutional and
qualified investors globally in the multi-billion dollar market of longevity
assets. Building on its well-established network, the Alpha Growth Group has a
unique position in the longevity asset services and investment business, as a
listed entity with global reach. The Group's strategy is to expand its
advisory and business services via acquisitions and joint ventures in the UK
and the US to attain commercial scale and provide holistic solutions to
alternative institutional investors who are in need of specialised skills and
unique access to deploy their financial resource in longevity assets.
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate, equity capital
and commodity markets. Its value is a function of time because as time
passes the value gets closer to the face value of the policy. Hence creating a
steady increase in the net asset value of the investment. This makes it highly
attractive to investors wishing to counteract volatility within an investment
portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets that originate
in the USA where the structured and life settlement market is highly
regulated.
Forward Looking Statements Disclaimer
Certain statements, beliefs and opinions in this document are forward-looking,
which reflect the Company's or, as appropriate, the Company's directors'
current expectations and projections about future events. By their nature,
forward-looking statements involve a number of risks, uncertainties and
assumptions that could cause actual results or events to differ materially
from those expressed or implied by the forward-looking statements. These
risks, uncertainties and assumptions could adversely affect the outcome and
financial effects of the plans and events described herein. Forward-looking
statements contained in this document regarding past trends or activities
should not be taken as a representation that such trends or activities will
continue in the future. The Company does not undertake any obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise. You should not place undue reliance
on forward- looking statements, which speak only as of the date of this
document. Readers should not treat the contents of this document as advice
relating to legal, taxation or investment matters, and are to make their own
assessments concerning these and other consequences, including the merits of
information and the risks. Readers of this announcement are advised to
conduct their own due diligence and agree to be bound by the limitations of
this disclaimer.
Important Notice
The content of this announcement has not been approved by an authorised person
within the meaning of the Financial Services and Markets Act 2000 (FSMA). This
announcement has been issued by and is the sole responsibility of the Company.
The information in this announcement is subject to change.
This announcement is not an offer of securities for sale into the United
States. The securities referred to herein have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the Securities
Act), and may not be offered or sold, directly or indirectly, in or into the
United States, except pursuant to an applicable exemption from registration.
No public offering of securities is being made in the United States. This
announcement is not for release, publication or distribution, directly or
indirectly, in or into the United States, Australia, Canada, the Republic of
South Africa, Japan or any jurisdiction where to do so might constitute a
violation of local securities laws or regulations (a Prohibited Jurisdiction).
This announcement and the information contained herein are not for release,
publication or distribution, directly or indirectly, to persons in a
Prohibited Jurisdiction unless permitted pursuant to an exemption under the
relevant local law or regulation in any such jurisdiction.
About BlackOak Alpha Growth Fund
The Fund was established by two highly experienced longevity asset management
companies. The Fund invests in life settlements, is a Cayman LP with a tax
efficient Master/Feeder structure in an open-ended format with quarterly
redemptions. The Fund seeks to provide well-diversified, non-correlated
returns. The Fund aims to achieve this objective through the acquisition of
secondary and tertiary Life Settlement policies that will be structured and
purchased to mitigate longevity risk and other investment and business risks
and where the Company's expertise can add value.
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCFFFLIFDILIIF